VANCOUVER, BRITISH COLUMBIA, CANADA, June 19, 2023/EINPresswire.com/ -- iData Research, a global consulting and market research firm, has just released exclusive research on the European Vascular Access Devices Market. The research provides valuable insights into market trends, developments, and competition. The European vascular access market is experiencing steady growth driven by the increasing adoption of safety devices that effectively mitigate needle-stick injuries. This emerging trend is particularly pronounced in the peripherally inserted venous catheter (PIVC) and syringe and needle segments, both of which hold substantial market shares within the broader vascular access market in Europe. The market is also encountering challenges that are hindering further growth. European healthcare facilities often prioritize lower-cost products, leading to price pressure. Additionally, the adoption of high-cost, premium products with features like antimicrobial coatings is still evolving in many markets. Thus, premiums are kept low with the market lacking a significant upward force from the conversion to these products.

According to iData's 2023 European Market Report for Vascular Access Devices, the market reached a valuation of just over €1.9 billion in 2022 and is projected to experience steady growth throughout the forecast period, reaching a value of almost €2.2 billion by 2029. This report suite includes procedure numbers, unit sales, average selling prices, market drivers and limiters, competitive market share analysis, and more.

iData's analysis also includes detailed segmentation on an astonishing 15 market segments within the European Vascular Access Devices Market. Some notable markets include central venous catheters (CVCs), peripherally inserted central catheters (PICCs), peripheral intravenous catheters (PIVCs), midline catheters, extended dwell catheters (EDCs) and the syringe and needle market.

In 2022, Becton Dickinson emerged as the leader in the European Vascular Access Device and Accessories market, maintaining its dominance through its acquisition of C.R. Bard. Becton Dickinson leads most market segments, with significant competition from B. Braun, which excels in various markets including implantable ports, port needles, CVCs, PIVCs, and syringes, making them the company with the second largest share in the European Vascular Access Market. 3M, specializing in catheter securement and catheter caps, holds the third largest market share due to its high-volume sales of catheter dressings and securement devices, widely used with catheters in Europe.

Key Questions Answered in this Report:
How has the European Vascular Access Device Market performed so far and how will it perform in the coming years?
What are the key regional markets?
What are the key driving factors and challenges in the industry?
What is the structure of the European Vascular Access Device Market and what are the market shares of the key players?
What is the degree of competition in the industry?

Follow the link below to download a Free Research Summary of the European Vascular Access Device Report:
https://idataresearch.com/product/vascular-access-devices-market-europe/

For Further Information
More insights like this can be found in the latest reports by iData. Please email us at info@idataresearch.net or register online for a brochure and synopsis.

About iData

iData Research is an international consulting and market research firm dedicated to empowering confident strategic decisions within the medical device, dental, and pharmaceutical industries.
www.idataresearch.com

Dejan Popic
iData Research
+1 604-266-6933
email us here
Visit us on social media:
Facebook
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.